|
|
Volumn 332, Issue 7536, 2006, Pages 255-
|
|
NEJM editor gives pretrial evidence in Vioxx case.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
LACTONE;
PROSTAGLANDIN SYNTHASE INHIBITOR;
ROFECOXIB;
SULFONE;
ARTICLE;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
CHEMICALLY INDUCED DISORDER;
DRUG INDUSTRY;
HEALTH CARE AND PUBLIC HEALTH;
HEART INFARCTION;
HUMAN;
LEGAL APPROACH;
LEGAL ASPECT;
MERCK INC.;
NEW ENGLAND JOURNAL OF MEDICINE;
PUBLICATION;
UNITED STATES;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
HEALTH CARE AND PUBLIC HEALTH;
LEGAL APPROACH;
MERCK INC.;
NEW ENGLAND JOURNAL OF MEDICINE;
CYCLOOXYGENASE INHIBITORS;
DRUG INDUSTRY;
HUMANS;
LACTONES;
MYOCARDIAL INFARCTION;
PERIODICALS;
SULFONES;
UNITED STATES;
|
|
EID: 33644845433
PISSN: None
EISSN: 14685833
Source Type: Journal
DOI: 10.1136/bmj.332.7536.255-a Document Type: Article |
|
Times cited : (3)
|
|
References (0)
|
